111 related articles for article (PubMed ID: 35448927)
1. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
2. Comparison of
Geng H; Li J; Zhang W
Heliyon; 2024 Jan; 10(1):e23922. PubMed ID: 38226231
[TBL] [Abstract][Full Text] [Related]
3.
Jiang Y; Wang L; Zhou W; Gu J; Tian Y; Dong Y; Fu L; Wu HB
Cancer Imaging; 2020 Jan; 20(1):4. PubMed ID: 31924270
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of
Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M
Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898
[TBL] [Abstract][Full Text] [Related]
5. Extranodal NK/T-Cell Lymphoma With Widespread Cutaneous and Subcutaneous Involvement on 18 F-FDG PET/CT.
Filizoglu N; Ozguven S; Ones T; Turoglu HT; Erdil TY
Clin Nucl Med; 2022 Oct; 47(10):e630-e631. PubMed ID: 35383610
[TBL] [Abstract][Full Text] [Related]
6. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.
Nakamura T; Tatetsu H; Higuchi Y; Endo S; Shiraishi S; Kawanaka K; Imakane D; Sonoda M; Furuta R; Shichijo T; Honda Y; Karube K; Mikami Y; Nosaka K; Matsuoka M; Yasunaga JI
J Clin Exp Hematop; 2024; 64(1):45-51. PubMed ID: 38538318
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV+ Cells (KROG 18-09).
Lee TH; Kim HJ; Lee JH; Lee J; Kim JH; Oh D; Eom KY
Cancer Res Treat; 2024 Apr; 56(2):688-696. PubMed ID: 38097921
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.
Wang H; Shen G; Jiang C; Li L; Cui F; Tian R
PLoS One; 2018; 13(3):e0194435. PubMed ID: 29558489
[TBL] [Abstract][Full Text] [Related]
9. Appropriate timing to perform an interim
Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M
Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892
[TBL] [Abstract][Full Text] [Related]
10. Primary Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma of Lower Limb Muscles on 18 F-FDG PET/CT.
Li C; Hu X
Clin Nucl Med; 2024 Jan; 49(1):e45-e46. PubMed ID: 37976527
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT in a Case of Esophageal Extranodal NK/T-Cell Lymphoma, Nasal Type.
Zhang J; Ji X; Dong A; Wang Y
Clin Nucl Med; 2023 May; 48(5):442-444. PubMed ID: 36727864
[TBL] [Abstract][Full Text] [Related]
12. Nasal-Type NK/T-Cell Lymphoma Involvement of the Vocal Cord on FDG PET/CT.
Huang M; Wang R; Shen G; Tian R
Clin Nucl Med; 2022 Oct; 47(10):914-915. PubMed ID: 35619195
[TBL] [Abstract][Full Text] [Related]
13. Value of
Zhang J; Jin F; Li C; Jiang W; Liu C; Zeng L; Jiang Y; Xu A; Fang N; Wang Y
Clin Imaging; 2024 Apr; 108():110100. PubMed ID: 38341881
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of pretreatment
Yang T; Liu S; Zuo R; Liang H; Xu L; Wang Z; Chen X; Pang H
BMC Med Imaging; 2023 Jan; 23(1):12. PubMed ID: 36681824
[TBL] [Abstract][Full Text] [Related]
15. Imaging features and clinical value of
Yi JW; Huang JF; Hou P; Lin ZK; Lin JS; Lin SY; Wang M; Li SY; Wang XL
Arthritis Res Ther; 2023 Oct; 25(1):198. PubMed ID: 37838717
[TBL] [Abstract][Full Text] [Related]
16.
Shen K; Yu M; Ji Y; Zhou X; Liu B; Zhang W; Su R; Qi J; Wang Q; Xue W
Prostate; 2023 Sep; 83(12):1167-1175. PubMed ID: 37189301
[TBL] [Abstract][Full Text] [Related]
17. Dissemination patterns of Hodgkin lymphoma using a probability network model based on [
Mouheb M; Pierre-Jean M; Fermé C; Devillers A; Lamy T; Le Jeune F; Houot R; Palard-Novello X
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1414-1422. PubMed ID: 36522437
[TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT may replace bone marrow biopsy for the evaluation of bone marrow involvement in selected mature T- and natural killer-cell lymphomas: A meta-analysis.
Guo L; Wang R; Hou N; Kuang A; Shen G
Eur J Radiol; 2024 Mar; 172():111353. PubMed ID: 38320330
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in patients with primary T cell lymphomas.
Zhang JH; Zhao J; Fan Y; Fu ZL; Zhang XC; Liu M; Zhao GY; Cen XN; Chen XQ; Ning J; Li X; Wang RF
Nucl Med Commun; 2022 Feb; 43(2):186-192. PubMed ID: 34783717
[TBL] [Abstract][Full Text] [Related]
20. Primary tumor SUV
Tas F; Ozturk A; Erturk K
Wien Klin Wochenschr; 2023 Sep; 135(17-18):478-487. PubMed ID: 36882606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
